High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis - Concepedia

Concepedia

Publication | Open Access

High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis

DOI Full Paper Access

311

Citations

32

References

2010

Year

U. Leuschner, Birgit Lindenthal, Günter Herrmann, Joachim C. Arnold, Martin Rössle, Hans-Jörg Cordes, Stefan Zeuzem, J Hein, Thomas Berg

Abstract

High-dose UDCA failed to improve the overall histology in patients with NASH in comparison with placebo.

References

	Year	Citations
Design and validation of a histological scoring system for nonalcoholic fatty liver disease† David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta, Hepatology Nafld Activity ScoreDiagnosisPathologyGastroenterologyFatty Liver Disease	2005	10.5K
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions Elizabeth M. Brunt, Christine G. Janney, Adrian M. Di Bisceglie, The American Journal of Gastroenterology	1999	3.8K
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆ Christi A Matteoni, Zobair M. Younossi, T GRAMLICH, Gastroenterology ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisHepatic DisordersHepatology	1999	3.4K
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome Giulio Marchesini, Elisabetta Bugianesi, Gabriele Forlani, Hepatology	2003	2.7K
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities Arun J. Sanyal, Carol Campbell–Sargent, Faridoddin Mirshahi, Gastroenterology ObesityMetabolic SyndromeInsulin ResistanceMetabolic Associated SteatohepatitisHepatology	2001	2.1K
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease Vlad Ratziu, Frédéric Charlotte, A. Heurtier, Gastroenterology HepatologyNonalcoholic Fatty Liver DiseaseLiver PhysiologyHistopathologyDiagnosis	2005	2K
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis Renata Belfort, Stephen A. Harrison, Kenneth Brown, New England Journal of Medicine	2006	1.8K
Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma Elisabetta Bugianesi, Nicola Leone, Ester Vanni, Gastroenterology Metabolic Associated SteatohepatitisHepatologyNonalcoholic Fatty Liver DiseaseLiver PhysiologyNatural History	2002	1.4K
Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia Jean‐Pierre Després, Alain Golay, Lars Sjöström New England Journal of Medicine ObesityMetabolic SyndromeCannabis UseBody CompositionHealth Sciences	2005	1.4K
Primary Biliary Cirrhosis HepatologyBiliary TractBiliary CancerGastroenterologyPathology	2011	1.2K

Page 1